Rajat Bose of rajatkbose.com told CNBC-TV18, "HPCL is a buy, it looks to me pretty good because in this market while other stocks have met their highs and sort of weakening, HPCL looks to me pretty good close to its high. I would put a stop loss below Rs 748.80 and chances are that it would re-visit the Rs 765 to Rs 775 zone, so the targets are Rs 765 and Rs 772." "Sun Pharmaceutical Industries is a sell. The stock is attracting lot of volume on the down side. I would put a stop loss above Rs 813 and put a target of Rs 780 to about Rs 773 on the downside. If Rs 773 to about Rs 770 range gets broken then Sun Pharma could well hit Rs 762 to about Rs 753 kind of range. So Sun Pharma is a sell and HPCL is a buy," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!